Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2020-05-04 Regulatory Filings
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Penthrox approved - Netherlands and Bosnia and Herzegovina 2 pages 167.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 5 May 2020 regarding the approval of the drug Penthrox in The Netherlands and Bosnia & Herzegovina. It discusses regulatory approvals, market entry, and reimbursement status but does not contain financial statements, earnings data, or detailed financial analysis. The document is relatively short (3722 characters) and serves as a corporate announcement about product approval and market status rather than a financial report or detailed investor presentation. It does not fit categories like Annual Report, Earnings Release, or Investor Presentation. It is not a report publication announcement since it does not mention an attached report or provide a link to a report. The content is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about product approval and market status without fitting into more specific categories.
2020-05-04 English
Penthrox is approved in Thailand 2 pages 164.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 28 April 2020, regarding the approval of Penthrox in Thailand by the Thailand Food and Drug Administration. It is a regulatory announcement about a product approval and market authorization, not a financial report, earnings release, or management discussion. The document is relatively short (4117 characters) and does not contain financial data or detailed financial analysis. It is not a report itself but an announcement of a regulatory milestone. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2020-04-27 English
Appendix 2A 15 pages 253.3KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the securities to be quoted, and references to previous announcements such as Appendix 3B. The document is a regulatory announcement related to the listing and quotation of securities rather than a financial report, earnings release, or management discussion. It is not a report itself but a formal application/notification to the exchange. This type of document fits best under Regulatory Filings (RNS) as it is a compliance and disclosure document related to securities quotation.
2020-04-21 English
Proposed issue of Securities - MVP 5 pages 27.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Medical Developments International Limited. It details the number of securities to be issued, the issue price, the purpose of the issue, and compliance with ASX listing rules. There is no financial statement or detailed financial analysis present, only information about the issuance of new shares. This fits the definition of a Share Issue/Capital Change announcement rather than a full financial report or other filing type.
2020-04-16 English
Proposed issue of Securities - MVP 5 pages 27.6KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Medical Developments International Limited. It details the type of securities, number of securities, issue price, purpose, and compliance with ASX listing rules. There is no financial statement or report content, only information about a capital raising event. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising or capital structure changes.
2020-04-02 English
COVID-19 Impact on MVP 2 pages 193.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 17 March 2020 discussing the impact of COVID-19 on Medical Developments International Limited (MVP). It provides operational updates such as stock levels, supply chain status, clinical program delays, and contingency plans. There are no financial statements, detailed financial data, or comprehensive report content. The document is relatively short (3498 characters) and serves as a business update rather than a formal financial report or regulatory filing. It does not announce voting results, management changes, or capital activities. It is a general regulatory announcement about business conditions related to COVID-19. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-03-16 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.